11 Apr. 2019

INVESTORS KEEN TO PUT MONEY INTO AMR SMES - BIOCOM CONFERENCE REPORT

nvestments into new drugs to tackle antimicrobial resistance (AMR) are set to boost the participation of SMEs. At the 11th Berlin Conference on Life S...


11 Apr. 2019

SME FINANCING AND MARKET ACCESS HURDLES IN THE FOCUS OF AMR CONFERENCE

200 experts followed invitation of BEAM Alliance and BIOCOM AG to build a discussion platform for most important AMR related challenges 50+ speakers...


11 Apr. 2019

SUCCESSFUL 11TH BERLIN CONFERENCE

BEAM Alliance and BioCom co-organized the 11th Berlin Conference on Novel Antimicrobials & AMR Diagnostics, which was a great success. The meeting...


11 Apr. 2019

NOVO HOLDINGS LAUNCHES €135M FUND TO COMBAT ANTIMICROBIAL RESISTANCE

Novo Holdings has launched the REPAIR impact fund commissioned by the Novo Nordisk Foundation. The goal is to invest into early-stage drug developers...